Adenovirus

27 registered clinical trials studyying Adenovirus — 10 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SO NCT07225972	New York Medical College	Phase 3
Recruiting	Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective NCT07358910	Institut Pasteur du Cambodge	—
Recruiting	Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Pati NCT06909110	Jessie L. Alexander	Phase 1 / Phase 2
Recruiting	R-MVST Cells for Treatment of Viral Infections in Children and Young Adults NCT06926894	Columbia University	Phase 1
Not Yet Recruiting	LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in S NCT06392451	DiaSorin Molecular LLC	N/A
Unknown	Effectiveness of a Single Dose of Betamethasone in Children With Symptomatic Adenovirus Infection NCT06299813	A.O.U. Città della Salute e della Scienza	Phase 3
Enrolling By Invitation	Anti-viral T-cell Therapy by Gamma Capture NCT06027879	Paul Szabolcs	Phase 1 / Phase 2
Recruiting	Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hemato NCT05664126	St. Jude Children's Research Hospital	Phase 2
Recruiting	R-MVST Cells for Treatment of Viral Infections NCT05183490	Columbia University	Phase 1
Recruiting	Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT NCT03665675	Sumithira Vasu	EARLY_Phase 1
Active Not Recruiting	Viral Specific T-Lymphocytes to Treat Adenovirus or CMV NCT04364178	Jessie L. Alexander	Phase 1 / Phase 2
Withdrawn	Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia NCT03532035	Jazz Pharmaceuticals	Phase 2
Recruiting	Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection NCT03266627	New York Medical College	Phase 2
Terminated	The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation NCT03339401	Jazz Pharmaceuticals	Phase 2
Unknown	Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics NCT03325517	Heba Momen kamel	—
Completed	Specific Respiratory Infections as Triggers of Acute Medical Events NCT02984280	University College, London	—
Terminated	A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection t NCT02420080	Jazz Pharmaceuticals	—
Completed	Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL) NCT01945814	Catherine Bollard	Phase 1
Unknown	Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transpl NCT02779439	University of Sydney	Phase 1
Completed	Interest of Rapid Typing in Adenovirus Infections. NCT04056546	University Hospital, Bordeaux	—
Unknown	Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus NCT01600365	Adapt Produtos Oftalmológicos Ltda.	Phase 3
Completed	Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV NCT01535885	Medical College of Wisconsin	Phase 1
Withdrawn	Adenovirus Vaccine Pregnancy Registry NCT01584037	Teva Branded Pharmaceutical Products R&D, Inc.	—
Completed	Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care NCT01431326	Daniel Benjamin	—
Unknown	Ad Sensor-based Real-time Diagnosis of Adenovirus NCT02008812	National Taiwan University Hospital	N/A
Withdrawn	Adenovirus and Fungal Load in Pediatric Stem Cell Transplant Patients NCT00448994	Steven B. Kleiboeker	—
No Longer Available	Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease NCT02596997	Jazz Pharmaceuticals	—